Targeted Alpha Therapy Symposium

Name: Targeted Alpha Therapy Symposium
Start: 2019-04-01T08:00:00+00:00
End: 2019-04-05T18:00:00+00:00
Location: Fairmont Château Laurier Hotel

Apr 1–5, 2019

Fairmont Château Laurier Hotel

UTC timezone

Details for Isabelle Quelven

Title: Dr

Affiliation: CRIBL, CNRS UMR 7276, INSERM 1262, University of Limoges, France ; Nuclear Medicine Department, Limoges University Hospital, France

Investigating the potential of 212Pb-rituximab as an alpha-radioimmunotherapy for the treatment of Non-Hodgkin’s Lymphoma

Choose timezone

Targeted Alpha Therapy Symposium

Author in the following contribution